Breaking the blisters: a comprehensive guide to treating bullous pemphigoid

Amber Subhan; Lolla Siddhartha; Mudimala Rekha Goud; Safura Khanam

doi:10.18203/2319-2003.ijbcp20251846

Authors

Amber Subhan Department of Pharmacy, Pulla Reddy Institute of Pharmacy, Hyderabad, India
Lolla Siddhartha Department of Pharmacy, Pulla Reddy Institute of Pharmacy, Hyderabad, India
Mudimala Rekha Goud Department of Pharmacy, Pulla Reddy Institute of Pharmacy, Hyderabad, India
Safura Khanam Department of Pharmacy, Pulla Reddy Institute of Pharmacy, Hyderabad, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20251846

Keywords:

Antibiotics, Bullous pemphigoid, Corticosteroids, Nicotinamides

Abstract

In adapting the treatment plan, the severity of the disease in correlation with the patient should be put onto consideration. Recent RCTs demonstrated adjuvant treatment with doxycycline, dapsone, and immunosuppressants for the treatment of bullous pemphigoid is of advantage and safe in terms of diminished total steroid dose and mortality. The British association of dermatologists has produced dermatologists’ guidelines. These provide evidence-based treatment recommendations with respect to candidness, and offer a summary on, among others, epidemiological features, diagnosis, and research. The evidence on which the guidelines rest was retrieved from Medline, Embase, the Cochrane Library, literature searches, and the authors' 10 years of experience treating patients with bullous pemphigoid in general and special clinics. However, it should be noted that findings from the literature should be interpreted with great care as only six randomized controlled trials with small patient groups are available.

Metrics

Metrics Loading ...

References

Lever WF. Pemphigus. Medicine. 1953;32(1):1-123. DOI: https://doi.org/10.1097/00005792-195302000-00001

Cruz PD Jr. Annual Trainee Awards for 1996 and 1997. Arch Dermatol. 1998;134(3):343. DOI: https://doi.org/10.1001/archderm.134.9.1137

Khumalo NP, Murrell DF, Wojnarowska F, Kirtschig G. A Systematic review of treatments for bullous pemphigoid. Arch Dermatol. 2002;138(3):385-9. DOI: https://doi.org/10.1001/archderm.138.3.385

Morel P, Guillaume JC. Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study. Ann Dermatol Venereol. 1984;111(10):925-8.

Burton JL, Harman RR, Peachey RD, Warin RP. Azathioprine plus prednisone in treatment of pemphigoid. BMJ. 1978;2(6146):1190-1. DOI: https://doi.org/10.1136/bmj.2.6146.1190

Roujeau J, Morel P, Dalle E, Guillot B, Gorin I, Lorette G, et al. Plasma exchange in bullous pemphigoid. The Lancet. 1984;324(8401):486-9. DOI: https://doi.org/10.1016/S0140-6736(84)92565-0

Anstey A. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol. 1993;129(9):1203. DOI: https://doi.org/10.1001/archderm.1993.01680300133025

Fivenson DP. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol. 1994;130(6):753. DOI: https://doi.org/10.1001/archderm.1994.01690060083010

Stevenson CJ. Treatment In Bullous Diseases with Corticosteroid Drugs and Corticotrophin. Brit J Dermatol. 1960;72(1):11-21. DOI: https://doi.org/10.1111/j.1365-2133.1960.tb13809.x

Church R. Pemphigoid treated with corticosteroids. Brit J Dermatol. 1960;72(12):434-8. DOI: https://doi.org/10.1111/j.1365-2133.1960.tb13838.x

Downham TF. Bullous pemphigoid. Arch Dermatol. 1978;114(11):1639. DOI: https://doi.org/10.1001/archderm.1978.01640230013003

Chosidow O, Saada V, Diquet B, Revuz J, Revuz J. Correlation between the pretreatment number of blisters and the time to control buUous pemphigoid with prednisone 1 mg/kg/day. Brit J Dermatol. 1992;127(2):185-6. DOI: https://doi.org/10.1111/j.1365-2133.1992.tb08055.x

Fine JD. Management of acquired bullous skin diseases. N Eng J Med. 1995;333(22):1475-84. DOI: https://doi.org/10.1056/NEJM199511303332207

Champion RH, Burton JL, Ebling FJG. Clinical Dermatology. Oxford; Blackwell Scientific. 5 ed. 1992.

Venning V, Wojnarowska F. Lack of predictive factors for the clinical course of bullous pemphigoid. J Am Academy Dermatol. 1992;26(4):585-9. DOI: https://doi.org/10.1016/0190-9622(92)70085-T

Person JR, Rogers RS, Perry HO. Localized pemphigoid. British J Dermatol. 1976;95(5):531-4. DOI: https://doi.org/10.1111/j.1365-2133.1976.tb00864.x

Siegel J. High-Dose methylprednisolone in the treatment of bullous pemphigoid. Arch Dermatol. 1984;120(9):1157. DOI: https://doi.org/10.1001/archderm.1984.01650450039014

Westerhof W. Treatment of bullous pemphigoid with topical clobetasol propionate. J Am Academy Dermatol. 1989;20(3):458-61. DOI: https://doi.org/10.1016/S0190-9622(89)70058-X

Zimmermann R. Prospective study of treatment of bullous pemphigoid with class I topical corticosteroid. J Eur Academy Dermatol Venereol. 1998;11:S138. DOI: https://doi.org/10.1016/S0926-9959(98)95056-5

Muramatsu T, Iida T, Shirai T. Pemphigoid and Pemphigus Foliaceus Successfully Treated with Topical Corticosteroids. J Dermatol. 1996;23(10):683-8. DOI: https://doi.org/10.1111/j.1346-8138.1996.tb02681.x

Spuls PI, Brakman M, Westerhof W, Bos JD. Treatment of generalized bullous pemphigoid with topical corticosteroids. Acta Dermato Venereologica. 1995;75(1):89. DOI: https://doi.org/10.2340/000155557589

Paquet P, Richelle M, Lapiere CM. Bullous pemphigoid treated by topical corticosteroids. Acta Dermato Venereologica. 1991;71(6):534-5. DOI: https://doi.org/10.2340/0001555571534535

Loche F, Bazex J, Giard A, Grolleau P, Marguery M. Efficacy and tolerability of topical corticosteroid treatment in the initial phase of bullous pemphigoid: An open study of 13 cases. J Dermatological Treat. 1995;6(2):69-72. DOI: https://doi.org/10.3109/09546639509097153

Joly P, Roujeau J, Benichou J, Picard C, Dreno B, Delaporte E, et al. A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid. N Eng J Med. 2002;346(5):321-7. DOI: https://doi.org/10.1056/NEJMoa011592

Fox BJ, Odom RB, Findlay RF. Erythromycin therapy in bullous pemphigoid: Possible anti-inflammatory effects. J Am Academy Dermatol. 1982;7(4):504-10. DOI: https://doi.org/10.1016/S0190-9622(82)70133-1

Alzolibani AA, Zedan K. Macrolides in chronic inflammatory skin disorders. Mediators Inflammation. 2012;1-7. DOI: https://doi.org/10.1155/2012/159354

Krausse S. Erythromycin in der Behandlung des bullösen Pemphigoids: vergleichende Untersuchung zur konventionellen Therapie. 1988.

Thomas I, Khorenian S, Arbesfeld DM. Treatment of generalized bullous pemphigoid with oral tetracycline. J Am Academy Dermatol. 1993;28(1):74-7. DOI: https://doi.org/10.1016/0190-9622(93)70013-J

Kimura K, Kawai K. Doxycycline as an initial treatment of bullous pemphigoid in Japanese patients. J Cutaneous Immunol Allergy. 2020;3(4):80-5. DOI: https://doi.org/10.1002/cia2.12126

Kolbach DN, Remme JJ, Bos WH, Jonkman MF, Jong MC, Pas HH, Meer JB. Bullous pemphigoid successfully controlled by tetracycline and nicotinamide. Brit J Dermatol. 2006;133(1):88-90. DOI: https://doi.org/10.1111/j.1365-2133.1995.tb02498.x

Hornschuh B, Hamm H, Wever S, Hashimoto T, Schröder U, Bröcker E, et al. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol. J Am Academy Dermatol. 1997;36(1):101-3. DOI: https://doi.org/10.1016/S0190-9622(97)70336-0

Venning V, Taghipour K, Mustapa MM, Highet A, Kirtschig G, Hughes J, et al. British Association of Dermatologists’ guidelines for the management of bullous pemphigoid 2012. Brit J Dermatol. 2012;167(6):1200-14. DOI: https://doi.org/10.1111/bjd.12072

Wojnarowska F, Kirtschig G, Highet A, Venning V, Khumalo N. Guidelines for the management of bullous pemphigoid. Brit J Dermatol. 2002;147(2):214-21.

Venning V, Millard P, Wojnarowska F. Dapsone as first line therapy for bullous pemphigoid. Brit J Dermatol. 1989;120(1):83-92. DOI: https://doi.org/10.1111/j.1365-2133.1989.tb07769.x

Bouscarat F, Chosidow O, Picard-Dahan C, Sakiz V, Crickx B, Prost C, et al. Treatment of bullous pemphigoid with dapsone: Retrospective study of thirty-six cases. J Am Academy Dermatol. 1996;34(4):683-4. DOI: https://doi.org/10.1016/S0190-9622(96)80085-5

Person JR. Bullous pemphigoid responding to sulfapyridine and the sulfones. Arch Dermatol. 1977;113(5):610. DOI: https://doi.org/10.1001/archderm.1977.01640050070009

Jeffes E, Ahmed A. Adjuvant therapy of bullous pemphigoid with dapsone. Clin Exp Dermatol. 1989;14(2):132-6. DOI: https://doi.org/10.1111/j.1365-2230.1989.tb00910.x

Itoh T, Hosokawa H, Shirai Y, Horio T. Successful treatment of bullous pemphigoid with pulsed intravenous cyclophosphamide. Brit J Dermatol. 1996;134(5):931-3. DOI: https://doi.org/10.1046/j.1365-2133.1996.131866.x

Heilborn JD, Ståhle-Bäckdahl M, Albertioni F, Vassilaki I, Peterson C, Stephansson E. Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid. J Am Academy Dermatol. 1999;40(5):741-9. DOI: https://doi.org/10.1016/S0190-9622(99)70156-8

Thivolet J, Barthelemy H, Rigot-Muller G, Bendelac A. Effects of cyclosporin on bullous pemphigoid and pemphigus. The Lancet. 1985;325(8424):334-5. DOI: https://doi.org/10.1016/S0140-6736(85)91099-2

Tappeiner G, Steiner A. High-dosage intravenous gamma globulin: Therapeutic failure in pemphigus and pemphigoid. J Am Academy Dermatol. 1989;20(4):684-5. DOI: https://doi.org/10.1016/S0190-9622(89)80148-3

Harman KE, Black MM. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Brit J Dermatol. 1999;140(5):865-74. DOI: https://doi.org/10.1046/j.1365-2133.1999.02817.x

Milligan A, Hutchinson PE. The use of chlorambucil in the treatment of bullous pemphigoid. J Am Academy Dermatol. 1990;22(5):796-801. DOI: https://doi.org/10.1016/0190-9622(90)70111-T

Egan CA, Meadows KP, Zone JJ. Plasmapheresis as a steroid saving procedure in bullous pemphigoid. Int J Dermatol. 2000;39(3):230-5. DOI: https://doi.org/10.1046/j.1365-4362.2000.00876.x

Miyamoto D, Santi CG, Aoki V, Maruta CW. Bullous pemphigoid. Anais Brasileiros De Dermatologia. 2019;94(2):133-46. DOI: https://doi.org/10.1590/abd1806-4841.20199007

Wojnarowska F, Kirtschig G, Highet A, Venning V, Khumalo N. Guidelines for the management of bullous pemphigoid. Brit J Dermatol. 2002;147(2):214-21. DOI: https://doi.org/10.1046/j.1365-2133.2002.04835.x